JERSEY CITY, N.J. and OR YEHUDA, Israel - Synchrony Medical, a medical technology company, has announced the launch of its LibAirty Airway Clearance System in the United States.
LibAirty is the first and only airway clearance system to synchronize controlled, app-guided breathing with targeted chest compressions—a clinically proven combination that helps patients clear more sputum than other therapies. Developed in collaboration with leading pulmonologists and inspired by the proven airway clearance technique of Autogenic Drainage, LibAirty transforms respiratory therapy into a simple, short, daily routine patients can easily perform independently at home, enabling effective lung disease management. The technology received FDA Clearance earlier this year.
Anat Shani, CEO of Synchrony Medical, said, "Synchrony Medical is redefining airway clearance. Our clinical studies showed that LibAirty enabled patients to clear twice as much sputum as standard vest-based therapy, with improved comfort and increased patient satisfaction. Through the launch of LibAirty in the United States, we look forward to bringing a new standard of care to people living with chronic lung disease across the country."
For patients with conditions such as chronic obstructive pulmonary disease (COPD), bronchiectasis, or cystic fibrosis, airway clearance is vital to managing symptoms, preventing infections and slowing disease progression. LibAirty provides a new generation of at-home airway clearance by guiding patients through breathing techniques while delivering synchronized chest compressions to direct airflow deep into the lungs to clear even hard-to-reach small airways.
Following FDA clearance received earlier this year and the establishment of its U.S. headquarters in Jersey City, New Jersey, Synchrony Medical is working with select healthcare providers, respiratory clinics, and home care partners to bring LibAirty to patients nationwide.
